Bradner, James E. (Jay) (Novartis 2016 President Novartis Institutes for BioMedical Research before Broad Institute) |
Professor |
Novartis (Group) |
Switzerland |
Bradway, Robert A. (Amgen 201403 CEO before CFO before Morgan Stanley) |
Chief Executive Officer (CEO) |
Amgen (Group) |
United States (USA) |
Braemisch, Fabian (Gilde Healthcare 201801– Partner of Healthcare Buy-out Team before Bridgepoint + Goldman Sachs) |
Partner (venture partner) |
Gilde Investment (Group) |
Germany |
Braggio, Simone (Evotec 202210 EVP, Partnership Management Excellence + Board Member at EXTEND) |
Business Development Manager / Strategy Manager |
Italy (govt) |
Italy |
Braglia, Riccardo (Helsinn Healthcare 200602 Managing Director) |
Managing Director |
Helsinn (Group) |
Switzerland |
Braguglia, Diego (VI Partners 201603) |
Investment Manager |
VI Partners AG |
Switzerland |
Brahms, Julie (Eppendorf 201604 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
Brain, Christopher (Chris) (Osteolabs 202105– General Manager of Osteolabs UK Ltd formerly Abbott + Cepheid + Roche Dx) |
General Manager (management) |
Osteolabs (Group) |
United Kingdom (GB) |
Brambilla, Gabriele (Alira Health 202005 CEO) |
Chief Executive Officer (CEO) |
Alira Health (CMC Consulting Boston) (Group) |
United States (USA) |
Brand, Alexandra (BASF 201305 SVP Animal Nutrition Business) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
Brand, Florian (ATAI Life Sciences 202004 CEO) |
Chief Executive Officer (CEO) |
Atai Life Sciences AG |
Germany |
Brand, Sabine (SBR Consulting 201504) |
Consultant (economic/technology) |
|
Germany |
Brandau-Krug, Barbara (ACD/Labs 200909– Account Manager Advanced Chemistry Development Germany GmbH) |
Sales Manager / Marketing Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
Germany |
Brandenberg, Nathalie (Sun Bioscience 202310 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
Switzerland |
Brandenburg, Mario (Member of German Parliament + Technology Policy Spokesman of FDP) |
n. a. |
|
|
Brander, Sonja |
n. a. |
Bayer (Group) |
Switzerland |
Brandicourt, Olivier (Sanofi 201508–201908 CEO before CEO of Bayer HealthCare before Pfizer Inc RETIRED 9/19) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
France |
Brandis, Hendrik (Earlybird 201807 Managing Director) |
Managing Director |
Earlybird (Group) |
Germany |
Brandkamp, Michael (ECBF 202001– General Partner before Managing Director at High-Tech Gründerfonds) |
Managing Director |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
Brandon, Roslyn (Immunexpress 201403 CEO) |
Chief Executive Officer (CEO) |
Immunexpress (Group) |
United States (USA) |
Brandt, Ralf (vivoPharma 201504 CEO + Founder before Head of Tumor Biology at Novartis AG) |
Chief Executive Officer (CEO) |
vivoPharm (Group) |
Australia |
Brandt, Stephan (Germany (govt) 201504 BMG Referat Biotech) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
Brandt, Werner (SAP 200102– CFO before Fresenius Medical Care before Baxter Deutschland) |
Chief Financial Officer (CFO) |
SAP (Group) |
Germany |
Brangwynne, Clifford P. (Princeton Univ 202011– Prof Dept of Chemical + Biological Engineering) |
Professor |
Princeton University |
United States (USA) |
Braspenning, Joris (Medicyte GmbH 201207 Managing Director (CEO + CSO)) |
Managing Director |
Medicyte GmbH |
Germany |
Brass, Laura (Novartis 201912 Managing Director at NVF) |
Managing Director |
Novartis (Group) |
Switzerland |
Brauer, Peer (Sartorius 201309 VP Finance at SSB) |
Chief Financial Officer (CFO) |
Sartorius (Group) |
France |
Braun, Anna Maria (B Braun 201807 President Asia Pacific) |
President/Director/Head Business Group/Unit/Division |
B. Braun (Group) |
Germany |
Braun, Dagmar (B Braun 202203 at Braun Beteiligungs GmbH) |
n. a. |
BBG/Braun Group (Group) |
Germany |
Braun, Helge (Germany (govt) 201011 Staatssekretär BMBF) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
Braun, Julia (Baker McKenzie 202205) |
Attorney / Lawyer |
Baker McKenzie LLP |
United States (USA) |
Braun, Volker (Evotec 202008– Head of Global Investor Relations + ESG) |
Public Relations Manager / Investor Relations Manager |
Evotec (Group) |
Germany |
Braunschweiler, Lukas (Sonova Holding + Tecan Board Chairman) |
Board member, non-executive |
Tecan (Group) |
Switzerland |
Braunstein, Guy (Actelion 201108 Head Clinical Development) |
Clinical Research Manager |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Bravetti, Paul (Brenus Pharma 202301 CEO) |
Chief Executive Officer (CEO) |
Brenus Pharma S.A. |
France |
Bravo, Eduardo (Life Sciences Partners 202103– Partner + CEO of EBAC before Nordic Nanovector + TiGenix + Cellerix) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Belgium |
Brea-Krüger, Mariana (IMI Consulting 200503 Managing Director) |
Managing Director |
IMI Consulting GmbH |
Germany |
Brecht, René (ProBioGen 2002– VP Process Science + Manufacturing before Univ Leipzig) |
n. a. |
Minapharm (Group) |
Germany |
Brégand, Eric (TEMIS 200809 CEO) |
Chief Executive Officer (CEO) |
Expert System (Group) |
France |
Breidbach, Andreas (EU (govt) 200609– EC-JRC-IRMM) |
Researcher (university / research institute) |
EU (govt) |
Belgium |
Breimesser, F. H. |
n. a. |
Siemens (Group) |
Germany |
Breiner, Klaus (BB Biotech Ventures + Vaximm 201605 Executive Chairman) |
Board member, executive |
Vaximm (Group) |
Switzerland |
Breitenstein, Urs (Nemis Technologies 202202 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
Nemis Technologies AG |
Switzerland |
Bremer, Ralf (Gerstel 201402 Managing Director, RnD + Production) |
Managing Director |
Gerstel (Group) |
Germany |
Brenker, Kathrin (Opto Biolabs 201906– Managing Director + Founder) |
Managing Director |
Opto BIolabs GmbH (formerly UG) |
Germany |
Brennan, John (EuropaBio –201808 Secretary General LEFT 9/18) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
Brennecke, Marcus (EQT Partners 201706 Partner + Investment Advisor to EQT VII fund) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
|
Brennecke, Thomas (Staatz Business Development & Strategy) |
consulting (economic) |
Staatz Business Development & Strategy – Dr. Irina Staatz-Granzer |
Germany |
Brenning, Thomas |
n. a. |
Helaba (Group) |
Germany |
Bresch, Heather (Mylan 201310 CEO) |
Chief Executive Officer (CEO) |
Mylan (Group) |
United States (USA) |
Bressi, Jeanette (MorphoSys 202012 Director US Communications) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
United States (USA) |
Brett, Catherine (Innovative Medicines Initiative 201807 External Relations Manager) |
President/Director/Head Business Group/Unit/Division |
Innovative Health Initiative (IHI JU) |
EU (European Union) |
Brett, Gerard (Vivasure Medical 201609 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Vivasure Medical Ltd. |
Ireland, Republic of |
Breu, Jessica (Immunic 201904 Manager IR + Communications) |
Public Relations Manager / Investor Relations Manager |
Immunic (Group) |
Germany |
Breu, Raymund (Novartis –2001003 CFO retires 3/10) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
Breuer, Sebastian (Genetics Company 200608 Program Manager Diagnostics) |
Product Manager (personnel) |
Genetics Company Inc., The |
Switzerland |
Breugelmans, Matthias (Elastrin 202209 CEO) |
Chief Executive Officer (CEO) |
Elastrin Therapeutics |
|
Breuker, Kathrin (Univ Innsbruck 201005 Principal Investigator Institute of Organic Chemistry) |
Researcher (university / research institute) |
University of Innsbruck |
Austria |
Brewis, Neil (F-Star 201611 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sino Biopharm (Group) |
United Kingdom (GB) |
Brichard, Vincent (Life Sciences Partners 2016– Venture Partner before GSK SVP + Head of Immunotherapeutics) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Netherlands |
Brickwedde, Fritz (DBU 200501) |
n. a. |
Deutsche Bundesstiftung Umwelt DBU |
Germany |
Briel, Andreas (NanoPET Pharma GmbH 201412 Managing Director) |
Managing Director |
NanoPET Pharma GmbH |
Germany |
Brilling, Julia (Norgenta 201211 Project Manager Industrial Cell Technology) |
Cluster Manager |
Hamburg (govt region) |
Germany |
Brinke-Seiferth, Stephan (i3 Membrane GmbH 201306– Managing Director + Founder) |
Managing Director |
i3 membrane GmbH |
Germany |
Brinkhaus, Franck (Biotech Alliances International Inc 201810 CEO before Woodside Capital Partners) |
Chief Executive Officer (CEO) |
Biotech Alliances International Inc. |
United States (USA) |
Brinkhoff, Günter |
n. a. |
BioAgency AG |
Germany |
Brinkmann, Klaus (Curetis 201112– Director of Sales before Bio-Rad (DE) + Becton Dickinson GmbH + Beckman Coulter GmbH) |
Sales Manager / Marketing Manager |
OpGen (Group) |
Germany |
Brinkmann, Maximilian (Max) (Refined Laser Systems 202301 Managing Director + Co-Founder) |
Managing Director |
Refined Laser Systems GmbH |
Germany |
Brinkmann, Thomas (Unilabs 201306 CMO) |
Chief Medical Officer (CMO) |
Unilabs (Group) |
Denmark |
Brinzey, Christopher F. (Chris) (Westwicke Partners 201703) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United States (USA) |
Brister, David (Evotec 200609– before MVM Ltd before 3i before Metal Box plc) |
n. a. |
Evotec (Group) |
Germany |
Britten, Cedrik (Immatics 202006– CMO before GSK VP + Head of Oncology Cell Therapy Research Unit + BioNTech) |
Chief Medical Officer (CMO) |
Immatics (Group) |
Germany |
Brix, Klaudia (Jacobs Univ Bremen 201104 Professor of Cell Biology) |
Professor |
Schaffhausen Institute of Technology (SIT) |
Germany |
Brkulj, Mario (MacDougall 201511 VP before MorphoSys + Biocom) |
Public Relations Manager / Investor Relations Manager |
MacDougall Biomedical Communications Inc. (MBI) |
Germany |
Brock, Stephan (Molecular Health 201401 CEO of European division before Metalife + LION Bioscience) |
Chief Executive Officer (CEO) |
Molecular Health (Group) |
Germany |
Brockhoff, Gero (Univ Regensburg 2006 Institute for Pathology) |
Researcher (university / research institute) |
University of Regensburg, Institute for Pathology (IPUR) |
Germany |
Brockmeyer, Carsten (Formycon 201305 CEO) |
Chief Executive Officer (CEO) |
Formycon (Group) |
Germany |
Brodard, Lionel (MedXCell 202106 CFO) |
Chief Financial Officer (CFO) |
MedXCell (Group) |
Switzerland |
Brodbeck, Sonja (co:bios Technologiezentrum 201104 Managing Director) |
Managing Director |
co:bios Technologiezentrum GmbH |
Germany |
Brodkorb, Mathias (Mecklenburg-Vorpommern (govt) 201312 Minister for Education + Science) |
Minister |
Mecklenburg-Vorpommern (govt region) |
Germany |
Broer, Wim (Cotecna 201712 Manager Developm + Science at NofaLab) |
n. a. |
Cotecna (Group) |
Netherlands |
Brons, Tim (Vida Strategic Partners 201907) |
Public Relations Manager / Investor Relations Manager |
Vida Strategic Partners |
United States (USA) |
Bronsema, Viola (BIO Deutschland 200905 Managing Director + CureVac 202008– Supervisory Board Member) |
Managing Director |
BIO Deutschland e. V. |
Germany |
Brooke, Paul (venBio 201204 Partner before Morgan Stanley) |
Partner (venture partner) |
VenBio (Group) |
United States (USA) |
Broom, Colin (Nabriva 201409– CEO before ViroPharma CSO) |
Chief Executive Officer (CEO) |
Nabriva (Group) |
Austria |
Brosch, Markus (Genedata 201905 Business Unit Head for Genedata Expressionist) |
Product Manager (personnel) |
Genedata (Group) |
Switzerland |
Brosnan, Michael (Fresenius Medical Care 201804 CFO + proposed to MorphoSys Supervisory Board) |
Chief Financial Officer (CFO) |
Fresenius (Group) |
Germany |
Brossmer, Reinhard (SialoTec GmbH 201601– Managing Director) |
Managing Director |
SialoTec GmbH |
Germany |
Brouillon, Carinne (Boehringer Ingelheim 201911 Head of Global Therapeutic Areas) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
Brown, Colin (Roche 201112 Head of Roche Professional Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
Brown, Gregory B. (Cowen 201206 Managing Director of Cowen Royalty) |
Managing Director |
TD Bank (Group) |
United States (USA) |
Brown, Paul (Roche 201103 Head Roche Molecular Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
Brown, Shaun (MC Services 201603) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Brown, Stephanie (Santhera 202112– President North America + Executive Board Member before Ipsen US + Novartis US) |
Board member, executive |
Santhera (Group) |
United States (USA) |
Browning, Rod (Xradia 201306 CEO) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
United States (USA) |
Bruce, Michael (Exo Therapeutics 202012 CEO) |
Chief Executive Officer (CEO) |
Exo Therapeutics Inc. |
United States (USA) |
Bruch, Jens (Italy (govt) 201603 ICE German Office) |
Administrative Officer (personnel) |
Italy (govt) |
Germany |
Bruchmann, Andreas (Axel Semrau 202111 Managing Director) |
Managing Director |
Trajan (Group) |
Germany |
Bruchmann, Dietrich (Nuvisan 2022 Managing Director of Nuvisan Pharma Holding GmbH) |
Managing Director |
Nuvisan (Group) |
Germany |
Bruchmann, Friderike (XO Life 202202 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
XO Life GmbH |
Germany |